EVALUATION OF ORAL CHANGES IN PATIENTS INFECTED WITH SARS-COV-2: SEVERE VERSUS CRITICAL COVID-19

Camilla Siqueira de Aguiar; José  Vital Alves Cabral; João Carlos Hazin de Godoy; Gyovanna Borges Pessoa; João Marcílio Coelho Netto Lins Aroucha; Gustavo Pina Godoy; Isabela Braz da Silva; Arnaldo de França Caldas Júnior

doi:10.54899/dcs.v22i79.57

Palabras clave:

efermedades de la boca

COVID 19

SARS-CoV-2

unidades de cuidados intensivos

habitaciones de pacientes

Resumen

Las personas infectadas con SARS-CoV-2 pueden desarrollar síntomas variados y las posibles manifestaciones bucales reportadas que se pueden observar son xerostomía, sialoadenitis, lesiones vesiculares ampollosas, lesiones ulceradas y disgeusia. El objetivo de este estudio fue evaluar comparativamente los cambios orales de personas infectadas con COVID-19 en salas y unidades de cuidados intensivos, en dos unidades de atención a pacientes COVID en Pernambuco, Brasil. Se trató de un estudio analítico con diseño transversal en el que participaron 30 pacientes adultos infectados con SARS-CoV-2 de ambos sexos. Se observaron condiciones sociodemográficas, síntomas, variables biomédicas de mantenimiento, así como cambios en los tejidos duros y blandos de la cavidad bucal. Para la recolección de datos se utilizó un formulario con información sociodemográfica e historia clínica. También se realizó un examen intraoral con los instrumentos CPO-D y CPI, así como diagnóstico de lesiones en la mucosa oral mediante examen físico. Los datos obtenidos en esta investigación fueron sometidos a pruebas estadísticas específicas analizadas en SPSS. Los pacientes analizados tenían una edad media de 64,47±2,74 años, de los cuales el 56,7% eran varones. Los individuos presentaban malas condiciones de higiene bucal, presentando el 63,3% un alto índice de caries (CPOD= 22,5), con problemas periodontales graves, además el 70% presentaba lesiones bucales al momento del examen. Según los hallazgos del presente estudio, se pudo concluir que las lesiones bucales fueron frecuentes en pacientes con COVID-19 en diferentes niveles sintomatológicos. También se observó que la mayoría de los pacientes analizados presentan una mala higiene bucal, con problemas periodontales y pérdida de dientes.
Citas
1. BEARN, D. R. et al. Index of Oral Cleanliness (IOC). A new oral hygiene index for use in clinical audit. British Journal of Orthodontics, v. 23, n. 2, p. 145-151, 1996.
2. BIADSEE, Ameen et al. Olfactory and oral manifestations of COVID-19: sex-related symptoms — a potential pathway to early diagnosis. Otolaryngology–Head and Neck Surgery, v. 163, n. 4, p. 722-728, 2020.
3. BRANDÃO, Thaís Bianca et al. Oral lesions in patients with SARS-CoV-2 infection: Could the oral cavity be a target organ?. Oral surgery, oral medicine, oral pathology and oral radiology, v. 131, n. 2, p. e45-e51, 2021.
4. CARRERAS‐PRESAS, Carmen Martín et al. Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection. Oral diseases, 2020.
5. CHI, Angela C. et al. Oral manifestations of systemic disease. American family physician, v. 82, n. 11, p. 1381-1388, 2010.
6. CIAGLIA, Elena; VECCHIONE, Carmine; PUCA, Annibale Alessandro. COVID-19 infection and circulating ECA2 levels: protective role in women and children. Frontiers in pediatrics, v. 8, p. 206, 2020.
7. COULTHARD, Paul. Dentistry and coronavirus (COVID-19)-moral decision-making. British Dental Journal, v. 228, n. 7, p. 503-505, 2020.
8. CRUZ TAPIA, Roberto Onneret al. Oral mucosal lesions in patients with SARS‐CoV‐2 infection. Report of four cases. Are they a true sign of COVID‐19 disease?. Special Care in Dentistry, v. 40, n. 6, p. 555-560, 2020.
9. DE MELO FILHO, Mário Rodrigues et al. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine. Head and neck pathology, v. 6, n. 1, p. 48-50, 2012.
10. DE SOUSA, Fernando Augusto Cervantes Garcia; PARADELLA, Thaís Cachuté. Considerations on oral manifestations of COVID‐19. Journal of Medical Virology, 2020.
11. DHINGRA, Kunaal; VANDANA, Kharidhi Laxman. Indices for measuring periodontitis: a literature review. International dental journal, v. 61, n. 2, p. 76-84, 2011.
12. DOS SANTOS, Juliana Amorim et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?. International Journal of Infectious Diseases, v. 97, p. 326-328, 2020.
13. DZIEDZIC, Arkadiusz; WOJTYCZKA, Robert. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral diseases, v. 27, p. 703-706, 2021.
14. FERNANDES, L. L. et al. Saliva in the diagnosis of COVID-19: a review and new research directions. Journal of Dental Research, v. 99, n. 13, p. 1435-1443, 2020.
15. GE, Zi-yu et al. Possible aerosol transmission of COVID-19 and special precautions in dentistry. Journal of Zhejiang University-SCIENCE B, v. 21, n. 5, p. 361-368, 2020.
16. GODINHO, Géssica Vasconcelos et al. Extensive hard palate hyperpigmentation associated with chloroquine use. British journal of clinical pharmacology, v. 86, n. 11, p. 2325-2327, 2020.
17. GORBALENYA, Alexander E. et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol, v. 5, n. 4, p. 536-544, 2020.
18. GU, Jinyang; HAN, Bing; WANG, Jian. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology, v. 158, n. 6, p. 1518-1519, 2020.
19. GUAN, Wei-jie et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, v. 382, n. 18, p. 1708-1720, 2020.
20. GUPTA, Aakriti et al. Extrapulmonary manifestations of COVID-19. Nature medicine, v. 26, n. 7, p. 1017-1032, 2020.
21. HINDSON, Jordan. COVID-19: faecal–oral transmission?. Nature Reviews Gastroenterology & Hepatology, v. 17, n. 5, p. 259-259, 2020.
22. HUANG, Chaolin et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497-506, 2020.
23. JIMENEZ‐CAUHE, Juan et al. Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings. Clinicaland experimental dermatology, 2020.
24. KAYA, Gürkan; KAYA, Aysin; SAURAT, Jean-Hilaire. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature. Dermatopathology, v. 7, n. 1, p. 3-16, 2020.
25. KLEIN, Henry; PALMER, Carroll E.; KRAMER, Morton. Studies on dental caries. II. The use of the normal probability curve for expressing the age distribution of eruption of the permanent teeth. Growth, v. 1, n. 385-394, p. 20, 1937.
26. LECHIEN, Jerome R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, v. 277, n. 8, p. 2251-2261, 2020.
27. LENTI, Marco Vincenzo et al. Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy. Internal and emergency medicine, v. 15, n. 8, p. 1399-1407, 2020.
28. MEHRA, Mandeep R. et al. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, 2020.
29. NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. Pub ChemDatabase. Ritonavir. 2020.
30. NOVAK, Natalijia et al. SARS‐CoV‐2, COVID‐19, skin and immunology–What do we know so far?. Allergy, v. 76, n. 3, p. 698-713, 2021.
31. PEDROSA, Marlus da Silva; SIPERT, Carla Renata; NOGUEIRA, Fernando Neves. Salivary glands, saliva and oral findings in COVID-19 infection. Pesquisa Brasileira em Odontopediatria e Clínica Integrada, v. 20, 2020.
32. PENG, Xian et al. Transmission routes of 2019-nCoV and controls in dental practice. International journal of oral science, v. 12, n. 1, p. 1-6, 2020.
33. REDWINE, Laura et al. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosomatic medicine, v. 65, n. 4, p. 598-603, 2003.
34. SABINO-SILVA, Robinson; JARDIM, Ana Carolina Gomes; SIQUEIRA, Walter L. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical oral investigations, v. 24, n. 4, p. 1619-1621, 2020.
35. SINGHANIA, Namrata et al. Current overview on hypercoagulability in COVID-19. American Journal of Cardiovascular Drugs, v. 20, n. 5, p. 393-403, 2020.
36. SOARES, Ciro Dantas et al. Letter to Editor: Oral lesions in a patient with Covid-19. Medicina oral, patologia oral y cirugia bucal, v. 25, n. 4, p. e563, 2020.
37. SPAGNUOLO, Gianrico et al. COVID-19 outbreak: an overview on dentistry. International Journal of Environmental Research and Public Health, v. 17, n. 6, p. 2094, 2020.
38. SPETH, Marlene M. et al. <? covid19?> Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngology–Head and Neck Surgery, v. 163, n. 1, p. 114-120, 2020.
39. TO, Kelvin Kai-Wang et al. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases, v. 71, n. 15, p. 841-843, 2020.
40. VINAYACHANDRAN, Divya; BALASUBRAMANIAN, Saravanakarthikeyan. Salivary diagnostics in COVID-19: Future research implications. Journal of dental sciences, v. 15, n. 3, p. 364, 2020.
41. WANG, Chenxing et al. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?. Medical hypotheses, v. 140, p. 109789, 2020.
42. WORLD HEALTH ORGANIZATION (WHO) et al. WHO health emergency dashboard—WHO (COVID-19) homepage. Vol. 2020. Webpage. World Health Organization, 2020.
43. WORLD HEALTH ORGANIZATION (WHO). Oral health surveys: basic methods. World Health Organization, 2nd ed. Geneva: World Health Organization, 2013; 127p.
44. XU, Hao et al. High expression of ECA2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science, v. 12, n. 1, p. 1-5, 2020.
45. YEO, Charleen; KAUSHAL, Sanghvi; YEO, Danson. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?. The lancet Gastroenterology & hepatology, v. 5, n. 4, p. 335-337, 2020.
46. ZHOU, Peng et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, v. 579, n. 7798, p. 270-273, 2020.
47. ZOU, Xin et al. Single-cell RNA-seq data analysis on the receptor ECA2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of medicine, p. 1-8, 2020.

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.

Derechos de autor 2025 Derecho y Cambio Social

##plugins.themes.gdAlpha.article.howToCite##

Aguiar, C. S. de, Cabral , J. . V. A., Godoy, J. C. H. de, Pessoa, G. B., Aroucha, J. M. C. N. L., Godoy, G. P., … Caldas Júnior, A. de F. (2025). ANÁLISIS DE CAMBIOS EM LA CAVIDAD ORAL EN PACIENTES INFECTADOS POR SARS-COV-2: COVID GRAVE X COVID CRÍTICO. Derecho Y Cambio Social, 22(79), e57. https://doi.org/10.54899/dcs.v22i79.57

[1] BEARN, D. R. et al. Index of Oral Cleanliness (IOC). A new oral hygiene index for use in clinical audit. British Journal of Orthodontics, v. 23, n. 2, p. 145-151, 1996.

[2] BIADSEE, Ameen et al. Olfactory and oral manifestations of COVID-19: sex-related symptoms — a potential pathway to early diagnosis. Otolaryngology–Head and Neck Surgery, v. 163, n. 4, p. 722-728, 2020.

[3] BRANDÃO, Thaís Bianca et al. Oral lesions in patients with SARS-CoV-2 infection: Could the oral cavity be a target organ?. Oral surgery, oral medicine, oral pathology and oral radiology, v. 131, n. 2, p. e45-e51, 2021.

[4] CARRERAS‐PRESAS, Carmen Martín et al. Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection. Oral diseases, 2020.

[5] CHI, Angela C. et al. Oral manifestations of systemic disease. American family physician, v. 82, n. 11, p. 1381-1388, 2010.

[6] CIAGLIA, Elena; VECCHIONE, Carmine; PUCA, Annibale Alessandro. COVID-19 infection and circulating ECA2 levels: protective role in women and children. Frontiers in pediatrics, v. 8, p. 206, 2020.

[7] COULTHARD, Paul. Dentistry and coronavirus (COVID-19)-moral decision-making. British Dental Journal, v. 228, n. 7, p. 503-505, 2020.

[8] CRUZ TAPIA, Roberto Onneret al. Oral mucosal lesions in patients with SARS‐CoV‐2 infection. Report of four cases. Are they a true sign of COVID‐19 disease?. Special Care in Dentistry, v. 40, n. 6, p. 555-560, 2020.

[9] DE MELO FILHO, Mário Rodrigues et al. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine. Head and neck pathology, v. 6, n. 1, p. 48-50, 2012.

[10] DE SOUSA, Fernando Augusto Cervantes Garcia; PARADELLA, Thaís Cachuté. Considerations on oral manifestations of COVID‐19. Journal of Medical Virology, 2020.

[11] DHINGRA, Kunaal; VANDANA, Kharidhi Laxman. Indices for measuring periodontitis: a literature review. International dental journal, v. 61, n. 2, p. 76-84, 2011.

[12] DOS SANTOS, Juliana Amorim et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?. International Journal of Infectious Diseases, v. 97, p. 326-328, 2020.

[13] DZIEDZIC, Arkadiusz; WOJTYCZKA, Robert. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral diseases, v. 27, p. 703-706, 2021.

[14] FERNANDES, L. L. et al. Saliva in the diagnosis of COVID-19: a review and new research directions. Journal of Dental Research, v. 99, n. 13, p. 1435-1443, 2020.

[15] GE, Zi-yu et al. Possible aerosol transmission of COVID-19 and special precautions in dentistry. Journal of Zhejiang University-SCIENCE B, v. 21, n. 5, p. 361-368, 2020.

[16] GODINHO, Géssica Vasconcelos et al. Extensive hard palate hyperpigmentation associated with chloroquine use. British journal of clinical pharmacology, v. 86, n. 11, p. 2325-2327, 2020.

[17] GORBALENYA, Alexander E. et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol, v. 5, n. 4, p. 536-544, 2020.

[18] GU, Jinyang; HAN, Bing; WANG, Jian. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology, v. 158, n. 6, p. 1518-1519, 2020.

[19] GUAN, Wei-jie et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, v. 382, n. 18, p. 1708-1720, 2020.

[20] GUPTA, Aakriti et al. Extrapulmonary manifestations of COVID-19. Nature medicine, v. 26, n. 7, p. 1017-1032, 2020.

[21] HINDSON, Jordan. COVID-19: faecal–oral transmission?. Nature Reviews Gastroenterology & Hepatology, v. 17, n. 5, p. 259-259, 2020.

[22] HUANG, Chaolin et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497-506, 2020.

[23] JIMENEZ‐CAUHE, Juan et al. Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings. Clinicaland experimental dermatology, 2020.

[24] KAYA, Gürkan; KAYA, Aysin; SAURAT, Jean-Hilaire. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature. Dermatopathology, v. 7, n. 1, p. 3-16, 2020.

[25] KLEIN, Henry; PALMER, Carroll E.; KRAMER, Morton. Studies on dental caries. II. The use of the normal probability curve for expressing the age distribution of eruption of the permanent teeth. Growth, v. 1, n. 385-394, p. 20, 1937.

[26] LECHIEN, Jerome R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, v. 277, n. 8, p. 2251-2261, 2020.

[27] LENTI, Marco Vincenzo et al. Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy. Internal and emergency medicine, v. 15, n. 8, p. 1399-1407, 2020.

[28] MEHRA, Mandeep R. et al. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, 2020.

[29] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. Pub ChemDatabase. Ritonavir. 2020.

[30] NOVAK, Natalijia et al. SARS‐CoV‐2, COVID‐19, skin and immunology–What do we know so far?. Allergy, v. 76, n. 3, p. 698-713, 2021.

[31] PEDROSA, Marlus da Silva; SIPERT, Carla Renata; NOGUEIRA, Fernando Neves. Salivary glands, saliva and oral findings in COVID-19 infection. Pesquisa Brasileira em Odontopediatria e Clínica Integrada, v. 20, 2020.

[32] PENG, Xian et al. Transmission routes of 2019-nCoV and controls in dental practice. International journal of oral science, v. 12, n. 1, p. 1-6, 2020.

[33] REDWINE, Laura et al. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosomatic medicine, v. 65, n. 4, p. 598-603, 2003.

[34] SABINO-SILVA, Robinson; JARDIM, Ana Carolina Gomes; SIQUEIRA, Walter L. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical oral investigations, v. 24, n. 4, p. 1619-1621, 2020.

[35] SINGHANIA, Namrata et al. Current overview on hypercoagulability in COVID-19. American Journal of Cardiovascular Drugs, v. 20, n. 5, p. 393-403, 2020.

[36] SOARES, Ciro Dantas et al. Letter to Editor: Oral lesions in a patient with Covid-19. Medicina oral, patologia oral y cirugia bucal, v. 25, n. 4, p. e563, 2020.

[37] SPAGNUOLO, Gianrico et al. COVID-19 outbreak: an overview on dentistry. International Journal of Environmental Research and Public Health, v. 17, n. 6, p. 2094, 2020.

[38] SPETH, Marlene M. et al. <? covid19?> Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngology–Head and Neck Surgery, v. 163, n. 1, p. 114-120, 2020.

[39] TO, Kelvin Kai-Wang et al. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases, v. 71, n. 15, p. 841-843, 2020.

[40] VINAYACHANDRAN, Divya; BALASUBRAMANIAN, Saravanakarthikeyan. Salivary diagnostics in COVID-19: Future research implications. Journal of dental sciences, v. 15, n. 3, p. 364, 2020.

[41] WANG, Chenxing et al. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?. Medical hypotheses, v. 140, p. 109789, 2020.

[42] WORLD HEALTH ORGANIZATION (WHO) et al. WHO health emergency dashboard—WHO (COVID-19) homepage. Vol. 2020. Webpage. World Health Organization, 2020.

[43] WORLD HEALTH ORGANIZATION (WHO). Oral health surveys: basic methods. World Health Organization, 2nd ed. Geneva: World Health Organization, 2013; 127p.

[44] XU, Hao et al. High expression of ECA2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science, v. 12, n. 1, p. 1-5, 2020.

[45] YEO, Charleen; KAUSHAL, Sanghvi; YEO, Danson. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?. The lancet Gastroenterology & hepatology, v. 5, n. 4, p. 335-337, 2020.

[46] ZHOU, Peng et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, v. 579, n. 7798, p. 270-273, 2020.

[47] ZOU, Xin et al. Single-cell RNA-seq data analysis on the receptor ECA2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of medicine, p. 1-8, 2020.

Resumen

Citas

##plugins.themes.gdAlpha.article.howToCite##